Clinical Trial Update: Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD) [Phase 3]

View source ↗

Summary

Phase 3 trial update on Vedolizumab subcutaneous maintenance therapy in Crohn's disease shows results after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2020-06-23